ADVISORY, Feb. 6, 2012 (GLOBE NEWSWIRE) -- What: Cepheid (CPHD), a leading molecular diagnostics company, will visit the NASDAQ MarketSite in New York City’s Times Square.
ADVISORY, Feb. 6, 2012 (GLOBE NEWSWIRE) -- What: Cepheid (CPHD), a leading molecular diagnostics company, will visit the NASDAQ MarketSite in New York City’s Times Square.